AILBRY - Article Search
Serach over 250 million academic articles from all areas of study
Results for 'Louis Fehrenbacher'
:
Eosinophilic Syndrome with Methylphenidate Abuse
Publication Year: 1978
DOI: https://doi.org/10.7326/0003-4819-89-2-224
Abstract:
Add to Library
Authors:
Tamoxifen in treatment of intraductal breast cancer: National Surgical Adjuvant Breast and Bowel Project B-24 randomised controlled trial
Publication Year: 1999
DOI: https://doi.org/10.1016/s0140-6736(99)05036-9
Abstract:
Add to Library
Authors:
Barbra M. Fisher
James W. Denham
Norman Wolmark
D. L. Wickerham
E R Fisher
E. Mamounas
Roy E. Smith
Mirsada Begovič
Nikolay V. Dimitrov
Richard G. Margolese
Carl G. Kardinal
Maureen Kavanah
Louis Fehrenbacher
Robert H. Oishi
Phase III Trial Assessing Bevacizumab in Stages II and III Carcinoma of the Colon: Results of NSABP Protocol C-08
Publication Year: 2011
DOI: https://doi.org/10.1200/jco.2010.30.0855
Abstract:
Add to Library
Authors:
Carmen J. Allegra
Greg Yothers
Michael J. O’Connell
Saima Sharif
Nicholas J. Petrelli
Linda H. Colangelo
James N. Atkins
Thomas E. Seay
Louis Fehrenbacher
Richard M. Goldberg
Séamus O’Reilly
Luis Chu
Catherine A. Azar
Samia Lopa
Norman Wolmark
Abstract S3-02: NSABP B-36: A randomized phase III trial comparing six cycles of 5-fluorouracil (5-FU), epirubicin, and cyclophosphamide (FEC) to four cycles of adriamycin and cyclophosphamide (AC) in patients (pts) with node-negative breast cancer
Publication Year: 2015
DOI: https://doi.org/10.1158/1538-7445.sabcs14-s3-02
Abstract:
Add to Library
Authors:
Jacobs A Samuel
John Wilson
Hanna Bandos
Richard Elledge
André Robidoux
Louis Fehrenbacher
Patrick J. Ward
Johnathan Polikoff
Adam Brufsky
Louise Provencher
Alexander Paterson
John Hamm
Robert L. Carolla
Luis Báez-Díaz
Priya Rastogi
Thomas B. Julian
D. Lawrence Wickerham
Sandra M. Swain
Charles E. Geyer
Eleftherios P. Mamounas
Norman Wolmark
Abstract 2837: A surrogate gene expression signature of tumor infiltrating lymphocytes (TILs) predicts degree of benefit from trastuzumab added to standard adjuvant chemotherapy in NSABP (NRG) trial B-31 for HER2+ breast cancer
Publication Year: 2015
DOI: https://doi.org/10.1158/1538-7445.am2015-2837
Abstract:
Add to Library
Authors:
Seong-Rim Kim
Patrick G. Gavin
Katherine L. Pogue–Geile
Nan Song
Melanie Finnigan
Hanna Bandos
Jong‐Hyeon Jeong
Priya Rastogi
Edward H. Romond
Louis Fehrenbacher
Eleftherios P. Mamounas
Sandra M. Swain
D. Lawrence Wickerham
Charles E. Geyer
Jos Jonkers
Norman Wolmark
Abstract GS4-01: Ten-year results from NRG Oncology/NSABP B-42: A randomized, double-blinded, placebo-controlled clinical trial of extended adjuvant endocrine therapy with letrozole (L) in postmenopausal women with hormone-receptor+ breast cancer (BC) who have completed previous adjuvant therapy with an aromatase inhibitor (AI)
Publication Year: 2020
DOI: https://doi.org/10.1158/1538-7445.sabcs19-gs4-01
Abstract:
Add to Library
Authors:
Eleftherios P. Mamounas
Hanna Bandos
Barry C. Lembersky
Jeon Hyeon Jeong
Charles E. Geyer
Priya Rastogi
Louis Fehrenbacher
Mark L. Graham
Stephen Chia
Adam Brufsky
Janice M. Walshe
Gamini S. Soori
Shaker R. Dakhil
Thomas E. Seay
James L. Wade
Edward C. McCarron
Soonmyung Paik
Sandra M. Swain
D. L. Wickerham
Norman Wolmark
Open-Label Study of Pemetrexed Alone or in Combination with Cisplatin for the Treatment of Patients with Peritoneal Mesothelioma: Outcomes of an Expanded Access Program
Publication Year: 2005
DOI: https://doi.org/10.3816/clc.2005.n.020
Abstract:
Add to Library
Authors:
Pasi A. Jänne
Agnieszka Woźniak
Chandra P. Belani
Mary Louise Keohan
Helen J. Ross
Jonathan Polikoff
David Mintzer
Loretta Taylor
Joseph Ashland
Zhishen Ye
Matthew Monberg
Coleman K. Obasaju
Abstract PD2-1: The effect on overall and disease-free survival (OS & DFS) by adding bevacizumab and/or antimetabolites to standard neoadjuvant chemotherapy: NSABP Protocol B-40
Publication Year: 2015
DOI: https://doi.org/10.1158/1538-7445.sabcs14-pd2-1
Abstract:
Add to Library
Authors:
Harry D. Bear
Gong Tang
Priya Rastogi
Charles E. Geyer
Qing Liu
André Robidoux
James N. Atkins
Luis Báez-Díaz
Adam Brufsky
Rita S. Mehta
Louis Fehrenbacher
James A. Young
Francis M. Senecal
Rakesh Gaur
Richard G. Margolese
Paul T. Adams
Howard M. Gross
Jos Jonkers
Soonmyung Paik
Sandra M. Swain
Eleftherios P. Mamounas
Norman Wolmark
Intrinsic Subtypes, <i>PIK3CA</i> Mutation, and the Degree of Benefit From Adjuvant Trastuzumab in the NSABP B-31 Trial
Publication Year: 2015
DOI: https://doi.org/10.1200/jco.2014.56.2439
Abstract:
Add to Library
Authors:
Katherine L. Pogue–Geile
Nan Song
Jong‐Hyeon Jeong
Patrick G. Gavin
Seong-Rim Kim
Nicole L. Blackmon
Melanie Finnigan
Priya Rastogi
Louis Fehrenbacher
Eleftherios P. Mamounas
Sandra M. Swain
D. Lawrence Wickerham
Charles E. Geyer
Jos Jonkers
Norman Wolmark
Soonmyung Paik
Long-Term Follow-Up of Cardiac Function and Quality of Life for Patients in NSABP Protocol B-31/NRG Oncology: A Randomized Trial Comparing the Safety and Efficacy of Doxorubicin and Cyclophosphamide (AC) Followed by Paclitaxel With AC Followed by Paclitaxel and Trastuzumab in Patients With Node-Positive Breast Cancer With Tumors Overexpressing Human Epidermal Growth Factor Receptor 2
Publication Year: 2017
DOI: https://doi.org/10.1200/jco.2017.74.1165
Abstract:
Add to Library
Authors:
Patricia A. Ganz
Edward H. Romond
Reena S. Cecchini
Priya Rastogi
Charles E. Geyer
Sandra M. Swain
Jong‐Hyeon Jeong
Louis Fehrenbacher
Howard M. Gross
Adam Brufsky
Patrick J. Flynn
Tanya A. Wahl
Thomas E. Seay
James L. Wade
David D. Biggs
James N. Atkins
Jonathan Polikoff
John L. Zapas
Eleftherios P. Mamounas
Norman Wolmark
Efficacy and safety of erlotinib in patients with locally advanced or metastatic breast cancer
Publication Year: 2008
DOI: https://doi.org/10.1007/s10549-008-0055-9
Abstract:
Add to Library
Authors:
Maura N. Dickler
Melody Cobleigh
Kathy D. Miller
Pamela Klein
Eric P. Winer
Angiosarcoma in Japan. A review of 99 cases
Publication Year: 1995
DOI: https://doi.org/10.1002/1097-0142(19950215)75:4<989::aid-cncr2820750414>3.0.co;2-k
Abstract:
Add to Library
Authors:
Norifumi Naka
Masahiko Ohsawa
Y. Tomita
Hiroyuki Kanno
Katsuyuki Aozasa
Atsushi Uchida
Cytokine Mechanisms of Central Sensitization: Distinct and Overlapping Role of Interleukin-1β, Interleukin-6, and Tumor Necrosis Factor-α in Regulating Synaptic and Neuronal Activity in the Superficial Spinal Cord
Publication Year: 2008
DOI: https://doi.org/10.1523/jneurosci.3338-07.2008
Abstract:
Add to Library
Authors:
Yasuhiko Kawasaki
Ling Zhang
Jen‐Kun Cheng
Ru‐Rong Ji
Physician-Researchers Have Key Role in Advancing Science, Forum Told
Publication Year: 2004
DOI: https://doi.org/10.1097/01.cot.0000293179.62326.f8
Abstract:
Add to Library
Authors:
Control of Macroautophagy by Calcium, Calmodulin-Dependent Kinase Kinase-β, and Bcl-2
Publication Year: 2007
DOI: https://doi.org/10.1016/j.molcel.2006.12.009
Abstract:
Add to Library
Authors:
Seungmin Hwang
Lone Bastholm
Piotr Szyniarowski
Michelangelo Campanella
György Szabadkai
Thomas Farkas
Katiuscia Bianchi
Nicole Fehrenbacher
Folmer Elling
Rosario Rizzuto
Ida Stenfeldt Mathiasen
Marja Jäättelä
Found 302 results in 0.093 seconds
What is Boolean Searches
Including any of the words AND
, OR
, or NOT
in any of your searches will enable
boolean search. Those words must be UPPERCASE . You can use this in all searches, including using
the search parameter, and using search filters.
This allows you to craft complex queries using those boolean operators along with parentheses and quotation marks.
Surrounding a phrase with quotation marks will search for an exact match of that phrase, after stemming and
stop-word removal (be sure to use double quotation marks — "
). Using parentheses will specify order of
operations for the boolean operators. Words that are not separated by one of the boolean operators will be
interpreted as AND
.
Behind the scenes, the boolean search is using Elasticsearch's query string query on the searchable fields (such as
title, abstract, and fulltext for works; see each individual entity page for specifics about that entity). Wildcard
and fuzzy searches using *
, ?
or ~
are not allowed; these characters will be
removed from any searches. These searches, even when using quotation marks, will go through the same cleaning as
described above, including stemming and removal of stop words.
Example Search
Search for works that mention "elmo"
and "sesame street"
, but not the words
"cookie"
or "monster"
:
"elmo" AND "sesame street" NOT "cookie" NOT "monster"